Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2025 , Vol 63 , Num 2
Preparation and in-vitro evaluation of Paclitaxel-loaded sericin nanoparticles planned for pulmonary drug delivery system
Mustafa EGLA 1 Nawal A. RAJAB 2
1 University of Al-Turath, School of Pharmacy, Department of Pharmaceutics, Baghdad, Iraq, 2 University of Baghdad, School of Pharmacy, Department of Pharmaceutics, Baghdad, Iraq DOI : 10.23893/1307-2080.APS6328

Summary

Istanbul Medipol University